Rockville biotech OpGen faces delisting threat from Nasdaq

The company's share price has languished below $1 for more than a month.

Source: bizjournals.com Health Care:Physician Practices headlines - June 13, 2023 Category: American Health Authors: Sara Gilgore Source Type: news